Cargando…
Immunophenotypes associated with bipolar disorder and lithium treatment
Immune dysfunction is implicated in the etiology of bipolar disorder. The single-nucleotide polymorphism rs17026688 in the gene encoding glutamate decarboxylase–like protein 1 (GADL1) has been found to be associated with lithium response in Han Chinese patients with bipolar I disorder (BDI). However...
Autores principales: | Wu, Tai-Na, Lee, Chau-Shoun, Wu, Bo-Jian, Sun, Hsiao-Ju, Chang, Chieh-Hsing, Chen, Chun-Ying, Chen, Chih-Ken, Wu, Lawrence Shih-Hsin, Cheng, Andrew Tai-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877517/ https://www.ncbi.nlm.nih.gov/pubmed/31767892 http://dx.doi.org/10.1038/s41598-019-53745-7 |
Ejemplares similares
-
Lithium and GADL1 regulate glycogen synthase kinase-3 activity to modulate KCTD12 expression
por: Wu, Tai-Na, et al.
Publicado: (2019) -
GADL1 variant and medication adherence in predicting response to lithium maintenance treatment in bipolar I disorder
por: Chen, Chih-Ken, et al.
Publicado: (2016) -
PS48. Genome-wide association study of psychotic subtype in bipolar I disorder
por: Lee, Chau-Shoun, et al.
Publicado: (2016) -
Genome-Wide Association Study of Lithium-Induced Dry Mouth in Bipolar I Disorder
por: Wu, Lawrence Shih-Hsin, et al.
Publicado: (2021) -
Antidepressant Treatment and Manic Switch in Bipolar I Disorder: A Clinical and Molecular Genetic Study
por: Chen, Chih-Ken, et al.
Publicado: (2022)